Discounted Cash Flow Rating

Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Enlivex Therapeutics Ltd. Ordinary Shares (ENLV)

https://www.enlivex.com

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/31/2014

Market Cap

26,089,750

Shares Outstanding

18,590,000

Weighted SO

18,598,555

Total Employees

N/A

Upcoming Earnings

09/06/2024

Similar Tickers

PLUR --.--%

BLRX --.--%

PPBT --.--%

ARDS --.--%

HSTO --.--%

PMVP --.--%

APVO --.--%

PLX --.--%

CRVS --.--%

Beta

0.9760

Last Div

0.0000

Range

1.15-4.59

Chg

0.0300

Avg Vol

57209

Mkt Cap

26089750

Exch

NASDAQ

Country

IL

Phone

972 8 662 3301

DCF Diff

1.2557

DCF

-0.0057

Div Yield

0.0000

P/S

0.0000

EV Multiple

-1.1622

P/FV

0.8718

Div Yield %

0.0000

P/E

-0.9007

PEG

-0.0277

Payout

0.0000

Current Ratio

7.8626

Quick Ratio

7.8626

Cash Ratio

0.5614

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

288.3231

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-0.0248

ROA

-0.8371

ROE

-0.7423

ROCE

-0.8134

NI/EBT

1.0000

EBT/EBIT

1.1645

EBIT/Rev

0.0000

Debt Ratio

0.0299

D/E

0.0346

LT Debt/Cap

0.0214

Total Debt/Cap

0.0334

Int Coverage

0.0000

CF/Debt

-23.7056

Equity Multi

1.1563

Rec Turnover

0.0000

Pay Turnover

1.2659

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.1747

FCF/Share

-1.1809

Cash/Share

1.2575

OCF/Sales

0.0000

FCF/OCF

1.0053

CF Coverage

-23.7056

ST Coverage

-64.5126

CapEx Coverage

-189.7475

Div&CapEx Cov

-189.7475

P/BV

0.8718

P/B

0.8718

P/S

0.0000

P/E

-0.9007

P/FCF

-1.1797

P/OCF

-1.0641

P/CF

-1.0641

PEG

-0.0277

P/S

0.0000

EV Multiple

-1.1622

P/FV

0.8718

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation